Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NutraMax repurchasing 47% of its outstanding stock from Mediq.

This article was originally published in The Tan Sheet

Executive Summary

NUTRAMAX BUYBACK OF 47% OF OUTSTANDING STOCK FROM MEDIQ for $9 a share was announced by the private label company Sept. 9. The repurchase agreement "concludes a comprehensive process that began more than one year ago, and will eliminate the overhang in the stock created by" ownership by the medical equipment supplier, NutraMax President and CEO Donald Lepone said.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS086021

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel